ArticleNature chemistry2026
Asymmetric synthesis of enantioenriched lactams from cyclic ketones via Beckmann rearrangement.
Article in Nature chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The direct incorporation of a single nitrogen atom into ketones or aldehydes represents one of the most valuable transformations for constructing amides and lactams, motifs that are ubiquitous in pharmaceutical manufacturing and industrial synthesis. Despite its importance, achieving precise stereochemical control in this process remains a formidable and long-standing challenge, primarily owing to the demanding reaction conditions typically required for such transformations. Here we show a highly enantioselective approach catalysed by a chiral phosphoric acid for the synthesis of enantioenriched five-membered to seven-membered lactams. This method uses prochiral cyclic ketones and readily available O-(sulfonyl)hydroxylamine reagents, proceeding via a Beckmann rearrangement with remarkable efficiency and stereocontrol. Our mechanistic investigations and theoretical calculations reveal that the sulfonyl-based leaving group plays a pivotal role in facilitating the rearrangement under mild conditions. This practical and robust protocol provides effective avenues for the efficient construction of chiral drug molecules, as demonstrated by the concise synthesis of the hydrochlorides of (R)-phenibut, (S)-pregabalin, (R)-baclofen, (R)-4-fluorophenibut, (R)-tolibut and (R)-phenotropil.
Identifiers
41688603What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.